| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | NEUTRAL | SELL | NEUTRAL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.82▼ | 3.74▲ | 3.72▲ | 3.87▼ | 4.05▼ |
| MA10 | 3.79▼ | 3.71▲ | 3.73▲ | 4.01▼ | 3.94▼ |
| MA20 | 3.74▲ | 3.74▲ | 3.73▲ | 4.14▼ | 3.63▲ |
| MA50 | 3.72▲ | 3.79▼ | 3.96▼ | 3.96▼ | 2.61▲ |
| MA100 | 3.76▲ | 3.98▼ | 4.11▼ | 3.50▲ | 2.87▲ |
| MA200 | 3.75▲ | 4.14▼ | 4.08▼ | 2.79▲ | 5.89▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.011▲ | 0.011▲ | 0.015▲ | -0.072▼ | -0.027▼ |
| RSI | 57.660▲ | 54.009▲ | 47.869▼ | 40.205▼ | 57.330▲ |
| STOCH | 87.932▲ | 63.959 | 39.158 | 32.574 | 61.308 |
| WILL %R | -39.394 | -29.545 | -32.609 | -76.824▼ | -61.724 |
| CCI | 47.493 | 158.397▲ | 75.926 | -126.687▼ | -80.333 |
| ▼ MACD | $SABS MACD(12,26,9) Crossed Below Zero | Set Alert |
|
Saturday, February 14, 2026 10:34 PM
SAB Biotherapeutics (NASDAQ:SABS) used a presentation at Guggenheim’s Emerging Outlook Biotech Summit 2026 to outline its strategy in type 1 diabetes (T1D), focusing on a pivotal Phase 2b program for ...
|
|
Wednesday, February 04, 2026 01:00 AM
MIAMI, Feb. 04, 2026 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing a fully human anti-thymocyte immunoglobulin (hATG) for type 1 ...
|
|
Monday, January 05, 2026 04:00 PM
MIAMI, Jan. 06, 2026 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing human anti-thymocyte immunoglobulin (hATG) for type 1 diabetes ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 19/02/26 | 3.745 | 3.85 | 3.63 | 3.785 | 188,234 |
| 18/02/26 | 3.81 | 3.865 | 3.64 | 3.74 | 176,606 |
| 17/02/26 | 3.87 | 3.89 | 3.515 | 3.88 | 480,861 |
| 13/02/26 | 4.15 | 4.15 | 3.82 | 3.85 | 274,624 |
| 12/02/26 | 4.17 | 4.265 | 4.06 | 4.12 | 307,376 |
| 11/02/26 | 4.20 | 4.30 | 3.94 | 4.18 | 339,810 |
| 10/02/26 | 4.21 | 4.24 | 4.035 | 4.18 | 250,927 |
| 09/02/26 | 4.22 | 4.295 | 4.04 | 4.23 | 246,182 |
| 06/02/26 | 3.94 | 4.28 | 3.75 | 4.17 | 383,893 |
| 05/02/26 | 4.20 | 4.35 | 3.95 | 3.98 | 290,657 |
|
|
||||
|
|
||||
|
|